EVO·30050E105·US·adr·Healthcare - Drug Manufacturers - Specialty & Generic-Activist
SPONSORED ADS
EVO (EVOTEC AG) is held by 23 institutional investors as of Q1 2026. Largest holders: Mubadala Investment Co PJSC ($11.5M), WCM INVESTMENT MANAGEMENT, LLC ($1.5M), Optiver Holding B.V. ($708,940). Net institutional sentiment: Mixed.
See how EVO's score breaks down across 4 SEC sources
Showing 1-20 of 29
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer